Investigation of associations between ABO blood group and the severity of COVID-19 patients admitted to Razi Hospital

Mohammad Rezaei, Morteza Rahbar, Maryam Yaseri, Aydin Pourkazemi, Alireza Badsar, Hamid Mohammadi Kojidi, Mohya Farzin, Mahsa Alipour Navi Motlagh

Abstract


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is the third strain of coronavirus with a possible zoonotic origin, which has been labeled deadly since the beginning of the new millennium. Due to various factors affecting the morbidity and mortality of coronavirus disease 2019 (COVID-19) and its various clinical syndromes, in this study we examined the relationship between the ABO blood group and the severity of COVID-19 patients. In this cross-sectional study, the required information was obtained by studying all records of patients with COVID-19 admitted to Razi Hospital in Rasht from April to May 2020. Information in patients' records including age, gender, clinical signs, blood type, high-resolution computed tomography (HRCT) findings, and nasopharyngeal tests was collected. In total, 548 cases were studied; of which 305 patients were male and 243 patients were female. The mean and standard deviation of patients' age was 58.15 ± 0.7 years. PCR test was performed for 195 patients. ABO positive/negative blood group was not significantly associated with disease severity in patients with COVID-19. The results of the present study showed that gender, age, history of underlying disease, disease severity, and ABO blood group were not significantly associated with disease severity. 


Keywords


ABO blood group; Coronavirus; COVID-19; Outcome

Full Text:

Full-text PDF

References


Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clinical Medicine. 2020;20(2):124.

Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Hu Y, Song Z-G, Tao Z-W, Tian J-H, Pei Y-Y. Complete genome characterization of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. BioRxiv. 2020.

Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. BioRxiv. 2020.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet. 2020;395(10224):565-74.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 2020.

Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, Tan K-S, Wang D-Y, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research. 2020;7(1):1-10.

Rodríguez-Morales AJ, MacGregor K, Kanagarajah S, Patel D, Schlagenhauf P. Going global–Travel and the 2019 novel coronavirus. Travel medicine and infectious disease. 2020;33:101578.

Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-l, Hui DS. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 2020;382(18):1708-20.

Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, Xing F, Liu J, Yip CC-Y, Poon RW-S. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The lancet. 2020;395(10223):514-23.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9.

Batool Z, Durrani SH, Tariq S. Association of ABO and Rh blood group types to hepatitis B, hepatitis C, HIV and Syphillis infection, a five year’experience in healthy blood donors in a tertiary care hospital. Journal of Ayub Medical College Abbottabad. 2017;29(1):90-2.

Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R. Human susceptibility and resistance to Norwalk virus infection. Nature medicine. 2003;9(5):548-53.

Guillon P, Clément M, Sébille V, Rivain J-G, Chou C-F, Ruvoën-Clouet N, Le Pendu J. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology. 2008;18(12):1085-93.

Hoffmann M, Kleine-Weber H, Krüger N, Mueller MA, Drosten C, Pöhlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv. 2020.

Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Journal of virology. 2020;94(7).

Tehrani S, Killander A, Åstrand P, Jakobsson J, Gille-Johnson P. Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients. International Journal of Infectious Diseases. 2021;102:415-21.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020;395(10229):1054-62.

Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G. Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. bmj. 2020;369.

Novel CPERE. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi. 2020;41(2):145.

Rate C-F. Characteristics of Patients Dying in Relation to COVID-19 in Italy Onder G, Rezza G, Brusaferro S. JAMA Published online March. 2020;23.

Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, Ma H, Chen W, Lin Y, Zheng Y. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China Life Sciences. 2020;63(5):706-11.

Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, Sepandi M, Jafari NJ, Izadi M, Qazvini A. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. Journal of Clinical Virology. 2020;127:104378.

Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. The Journal of Immunology. 2017;198(10):4046-53.

Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clinical reviews in allergy & immunology. 2019;56(3):308-21.

Cheng Y, Cheng G, Chui C, Lau F, Chan PK, Ng MH, Sung JJ, Wong RS. ABO blood group and susceptibility to severe acute respiratory syndrome. Jama. 2005;293(12):1447-51.

Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2020;510:475.

Guan W-j, Liang W-h, Zhao Y, Liang H-r, Chen Z-s, Li Y-m, Liu X-q, Chen R-c, Tang C-l, Wang T. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. European Respiratory Journal. 2020;55(5).

Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, Zhang Z, Liu L, Liu T, Liu Y. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. Clinical Infectious Diseases. 2020.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.